Pharma company Opko acquires smart inhaler startup for at least $10M

Biopharmaceutical company Opko Health has acquired Israeli smart inhaler company Inspiro Medical for a sum in “the low eight figures”, according to Opko’s Director of Strategic Investment Les Funtleyder. The company will be using Inspiro’s Inspiromatic technology to develop an app-connected inhaler that will be bundled with a forthcoming new drug for asthma, COPD, and [...]
Source: mobihealthnews - Category: Information Technology Authors: Tags: Uncategorized asthma connected inhaler COPD cystic fibrosis Inspiro Medical Inspiromatic mobile health mergers and acquisitions Opko Health pharma smart inhaler Source Type: news